Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.670
+0.060 (3.73%)
At close: Jul 3, 2025, 1:00 PM
1.698
+0.028 (1.69%)
After-hours: Jul 3, 2025, 4:36 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $62.43 million as of July 3, 2025. Its market cap has decreased by -60.42% in one year.
Market Cap
62.43M
Enterprise Value
-119.11M
1-Year Change
-60.42%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $62.43M, a decrease of -88.91%. That is a compound annual growth rate of -79.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 62.43M | -53.79% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |